APPENDIX 4
Memorandum submitted by Apax Partners
& Co Ventures Ltd
INTRODUCTION
1. Apax Partners provides private equity
funding, corporate finance advice and asset management to entrepreneurial
businesses internationally. We are one of the largest private
equity organisations operating from 12 offices, across Europe,
the US, Israel and Japan, and managing or advising private equity
funds with capital totalling about £3\5 billion at current
exchange rates. These funds are provided by many of the world's
leading institutional investors through 27 funds and they are
currently invested in over 150 companies. UK funds under management
exceed £2 billion.
SUMMARY
2. We believe that several factors mentioned
in your terms of reference influence companies in the field of
engineering and physical sciences when deciding on developing
new products and processes. In particular, we have some suggestions
with regard to:
Tax incentives for entrepreneurs
(reduction in CGT and taxation on stock options).
Effective stock markets for growth
companies (support for EASDAQ, the European Association of Securities
Dealers and Automated Quotations; extension of the AIM relief,
including rollover relief, to smaller listed companies with market
capitalisations of £50 million or less; support for the EC's
"IPO Europe" initiative to facilitate equity offerings
across the whole of the EC; and removal of the current anomaly
which favours raising debt rather than equity by allowing debt-raising
expenses to be deducted against corporation tax but making equity-raising
expenses non-deductible).
The funding of hi-tec businesses
(replicate the US's SBIR programme; introduce grants to equip
university labs; set up incubators; provide R&D grants to
fund scientists carrying out research with commercial applications;
encourage creation of "technology clusters" and easing
of planning restrictions for them).
3. The Government must recognise the importance
of successful entrepreneurship. The result will not only be the
creation of successful role models of quality growth companies
but also the encouragement of an entrepreneurial "can-do"
culture where commercial success is admired, not envied, and where
failure is forgiven as part of the entrepreneurial process of
trial and error.
EVIDENCE
4. In the US, growth companies are the engine
of future wealth and employment creation throughout the economy.
They should be the same in the UK, but in order to achieve this,
and to build on the UK's strong base in science, technology and
creativity, they and those who invest and work in them must be
given the right environment for risk-taking and reward.
Taxation
5. The most effective step that this Government
can take towards improving the entrepreneurial environment is
a reduction in Capital Gains Tax. For long-term investors in high-risk
companies, the current rate of 40 per cent is too high and acts
as a disincentive to make adequate funds available on the right
terms to entrepreneurs. Entrepreneurship is thus constrained and
promising research and development is left unfinanced or exploited
outside the UK under more favourable tax regimes.
6. There is a strong case in the UK for
a lower overall rate of CGT, initially at 20 per cent, for investments
held for three years or more. There is also a very strong case
to apply such a rate without the complexities of tapering or qualifying
periods. In the US, the substantial reductions in CGT at the end
of the 1970s helped to ensure a greatly increased inflow of capital
into smaller companies precisely because they created a powerful
tax incentive for entrepreneurs and investors alike to become
involved with illiquid, long-term investment in high-risk growth
companies.
7. In the US, the CGT tax incentives have
engendered a virtuous circle of risk-taking, wealth creation and
reinvestment of capital gains in new ventures, which we see today
in Silicon Valley and elsewhere. In 1997, to give a further impetus
to this process, which helped create 65 million jobs in the period
1980-1995 while 42 million jobs were lost by mature companies,
the US has again reduced the general rate of CGT, from28 per cent
to 20 per cent, and that for investments held for more than five
years in companies with assets of up to $50 million has been reduced
to only 14 per cent.
8. This contrasts with a US federal income
tax rate of 40 per cent. The US has, clearly, found that the benefit
to its economy and the gain to its Revenue over the life of the
firms created and developed overshadows any possible leakage from
tax avoidance.
9. A similarly bold reduction of CGT by
this Government would have a powerful impact on UK small company
creation and growth, including the creation and growth of "tech-stars".
We recommend a simple reduction to 20 per cent on investments
held for three years or more.
10. Another area of taxation which should
be addressed by the Government is that governing stock options
over shares in smaller companies. For the same reasons, we recommend
that all gains on options held for three years or more by employees
be treated as capital rather than income, and that the rate of
CGT be reduced and the structure simplified by removing the complicated
indexation rules. We recommend that for future grants of options,
the CGT rate of 20 per cent apply for stock options exercised
after three years or more over the shares of companies less than
five years old and with assets of £30 million or less.
11. The Government should recognise that
our tax environment for long-term high-risk capital has to be
competitive with the US if we are to develop in the UK the technologies
and managerial skills we need to fulfil our economic aspirations.
Effective stock markets for growth companies
12. One of the reasons for low levels of
investment in early stage growth companies in the UK and more
generally in Europe is the failure of the European financial system.
Growth companies need to be able to access the public equity markets
in order to obtain finance when the venture capitalist leaves
off. For the venture capital industry is merely one part of the
system. The system involves taking illiquid and "patient"
money, in the main from pension funds and insurance companies,
and backing new businesses. As these businesses grow, they consume
increasing amounts of cash. And the ability of venture capital
funds to provide funds to finance their growth is necessarily
limited, while the cost of venture capital finance is higher than
that of equity raised through the stockmarket. So, once the risk
of the venture has fallen sufficiently and its potential can be
better measured, the venture capitalist needs to be able to float
promising companies on a stockmarket and raise much larger amounts
of money from a wider group of investors at a relatively lower
cost. One consequence of a successful flotation is that the company's
progress will then be reflected in an attractive valuation which
will give comfort to the initial shareholders, including the venture
capitalist and investors in the venture capital fund. These investors
will then be encouraged to recycle any distribution they receive
and to increase the allocation they make to venture capital.
13. US venture capitalists will confirm
that NASDAQ has been and still is absolutely essential to the
development of the US venture capital industry, and that its effectiveness
as a stockmarket for growth companies has attracted investment
into venture capital funds specialising in early stage investment.
NASDAQ has developed into a powerful stockmarket for growth companies
because it has set out to specialise in them and to be highly
regulated against fraud but not against business risk. It has
a clear entrepreneurial identity which appeals to managers of
entrepreneurial companies, and so attracts new companies as new
technologies evolve. And it is managed independently of the NYSE
and the American Stock Exchange, which concentrate on larger,
more stable companies.
14. As a result, NASDAQ has led to the creation
or development of new investment banks and market makers such
as Robertson Stephens, Hambrecht & Quist, Alex Brown, Montgomery
Securities and Cowen & Co., which specialise in growth companies
and which realise that the less profitable a company is, the more
investors need full and frequent disclosure about its prospects.
These investment banks have assembled powerful analysts specialising
in growth areas such as telecoms, biotech, information technology
and media who continually monitor companies and keep the public
and the investment community well informed about them. NASDAQ
has also led to the creation of a multitude of specialist investment
funds which focus on every type of growth company listed on NASDAQ.
All of this creates liquidity for the shares of NASDAQ quoted
companies.
15. The UK and more generally Europe also
need a stockmarket specialising in growth companies in order to
encourage early stage investment. We need an effective pan-European
market modelled on NASDAQ which channels funds from European and
US investors to European growth companies. This is why EASDAQ
(European Association of Securities Dealers and Automated Quotations)
has been set up.
16. EASDAQ has developed, with the help
of NASDAQ, as an independent exchange backed by 93 prominent institutional
investors, bankers and venture capitalists from the UK, Continental
Europe, Israel and the USA. EASDAQ's focus is on European growth
companies with international aspirations. EASDAQ has offices in
Brussels, London, Frankfurt and Paris. In order to maximise liquidity,
it has concentrated on companies with a market capitalisation
of $100 million or more. To provide companies with maximum flexibility,
it has made it easy to obtain either a single listing on EASDAQ
or a dual listing on EASDAQ and NASDAQ, thus enabling growth companies
with international aspirations to access both the US and European
public equity markets.
17. Support should therefore be given to
EASDAQ, as a pan-European stock market capable of playing a similar
role to that of NASDAQ in the US. After all, it is thanks to this
system that sectors such as semi-conductors, personal computers,
biotechnology and the Internet have been financed in the USA,
including companies like Intel, Apple and Genentech.
18. In the UK, further support should be
shown by extending the AIM relief, including rollover relief,
to smaller listed companies with market capitalisations of £50
millon or less. The Government should also support the EC's "IPO
Europe" initiative to facilitate equity offerings across
the whole of the EC and the Government should remove the current
anomaly which favours raising debt rather than equity by allowing
debt-raising expenses to be deducted against corporation tax but
making equity-raising expenses non-deductible.
Importance of hi-tec funding
19. The third key area of support for the
creation of growth companies is the provision of funding forhi-tec
companies. Again, we can learn from the US where the Government
has initiated the Small Business Innovation Research programme,
the purpose of which is to create new technologies that offer
solutions to the nation's most pressing scientific and engineering
problems. In 1998, the Federal SBIR programme will fund more than
$1 billion in early-stage R&D projects at small hi-tech firmsprojects
with the potential for commercialisation in private and government-sector
markets. Small businesses (500 or fewer employees), as well as
individual entrepreneurs seeking to start a small business, are
eligible to apply.
20. We recommend replicating the SBIR in
the UK, and allocating 2 per cent of the annual government research
institutions' spending to grants for high R&D commercial projects.
Other recommendations are to introduce grants to equip university
labs, to set up incubators, and to provide R&D grants to fund
scientists carrying out research with commercial applications.
21. Hi-tec growth companies are best created
through "technology clusters". Several examples exist
both within the UK and Continental Europe. In the UK, there are
specialisations in IT in Cambridge, in semi-conductors in Glenrothes,
in man/machine interface in Leicester and in software in the Thames
Valley. In Continental Europe, there are specialisations in software
in Louvain (Belgium), in IT and Biotech in Sofia Antipolis (France)
and in Biotech in Heidelberg (Germany). A technology cluster requires
a concentration of a higher centre of learning and/or a Government
research establishment, a science park together with a reasonable
quality of life environment, effective incubators and the availability
of finance through angels, seed finance or venture capital. This
concentration leads to a crystallisation of important networks
(scientific, sub-contracting, social, technical, managerial and
financial), all of which in turn help to create successful role
models and a "can-do" culture.
22. Support should be given for the establishment
of such technology clusters, and we should ease the planning restrictions
for them to be located near universities.
23 February 1998
|